Microbiome in brain function and mental health

Trends in Food Science and Technology

Volumn 57, Issue , 2016, Pages 289-301

  Kennedy, Paul J ^a   Murphy, Amy B ^a,c   Cryan, John F ^a,b   Ross, Paul R ^a,b   Dinan, Timothy G ^a,b   Stanton, Catherine ^a,b,c  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c TEAGASC FOOD RESEARCH CENTRE   (Ireland)

Author keywords

Brain function; Functional food; Gut microbiota; Mental health; Microbiota gut brain axis; Psychiatric disorder

Indexed keywords

BEHAVIORAL RESEARCH; HEALTH;

BRAIN FUNCTIONS; GUT MICROBIOTA; MENTAL HEALTH; MICROBIOTAS; PSYCHIATRIC DISORDERS;

FUNCTIONAL FOOD;

EID: 84999810239     PISSN: 09242244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tifs.2016.05.001     Document Type: Article

References (111)

1. Adlerberth, I., Wold, A.E., Establishment of the gut microbiota in Western infants. Acta Paediatrica 98 (2009), 229–238.
2. Al Khalaf, S.Y., O'Neill, S.M., O'Keeffe, L.M., Henriksen, T.B., Kenny, L.C., Cryan, J.F., et al. The impact of obstetric mode of delivery on childhood behavior. Social Psychiatry and Psychiatric Epidemiology, 2015, 1–11.
3. Amminger, G., Schäfer, M.R., Papageorgiou, K., et al. Long-chain ω-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Archives of General Psychiatry 67 (2010), 146–154.
4. Antypa, N., Van der Does, A., Smelt, A., Rogers, R., Omega-3 fatty acids (fish-oil) and depression-related cognition in healthy volunteers. Journal of Psychopharmacology 23 (2009), 831–840.
5. Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D.R., et al. Enterotypes of the human gut microbiome. Nature 473 (2011), 174–180.
6. Atladóttir, H.O., Thorsen, P., Østergaard, L., Schendel, D.E., Lemcke, S., Abdallah, M., et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. Journal of Autism and Developmental Disorders 40 (2010), 1423–1430.
7. Aziz, Q., Thompson, D.G., Brain-gut axis in health and disease. Gastroenterology 114 (1998), 559–578.
8. Barrett, E., Ross, R.P., O'Toole, P.W., Fitzgerald, G.F., Stanton, C., γ-Aminobutyric acid production by culturable bacteria from the human intestine. Journal of Applied Microbiology 113 (2012), 411–417.
9. Benton, D., Williams, C., Brown, A., Impact of consuming a milk drink containing a probiotic on mood and cognition. European Journal of Clinical Nutrition 61 (2007), 355–361.
10. Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141 (2011), 599–609 e593.
11. Bloch, M.H., Hannestad, J., Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Molecular Psychiatry 17 (2012), 1272–1282.
12. Borre, Y.E., O'Keeffe, G.W., Clarke, G., Stanton, C., Dinan, T.G., Cryan, J.F., Microbiota and neurodevelopmental windows: implications for brain disorders. Trends in Molecular Medicine 20 (2014), 509–518.
13. Bravo, J.A., Forsythe, P., Chew, M.V., Escaravage, E., Savignac, H.M., Dinan, T.G., et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proceedings of the National Academy of Sciences 108 (2011), 16050–16055.
14. Casini, M.L., Marelli, G., Papaleo, E., Ferrari, A., D'Ambrosio, F., Unfer, V., Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: a randomized, double-blind, crossover, placebo-controlled study. Fertility and Sterility 85 (2006), 972–978.
15. Chassaing, B., Koren, O., Goodrich, J.K., Poole, A.C., Srinivasan, S., Ley, R.E., et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 519 (2015), 92–96.
16. Chung, Y.-C., Jin, H.-M., Cui, Y., Kim, D.S., Jung, J.M., Park, J.-I., et al. Fermented milk of Lactobacillus helveticus IDCC3801 improves cognitive functioning during cognitive fatigue tests in healthy older adults. Journal of Functional Foods 10 (2014), 465–474.
17. Claesson, M.J., Jeffery, I.B., Conde, S., Power, S.E., O'Connor, E.M., Cusack, S., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 488 (2012), 178–184.
18. Clarke, G., Cryan, J., Dinan, T., Quigley, E., Review article: probiotics for the treatment of irritable bowel syndrome–focus on lactic acid bacteria. Alimentary Pharmacology & Therapeutics 35 (2012), 403–413.
19. Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R., Shanahan, F., et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Molecular Psychiatry 18 (2012), 666–673.
20. Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R.D., Shanahan, F., et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Molecular Psychiatry 18 (2013), 666–673.
21. Clarke, G., McKernan, D.P., Gaszner, G., Quigley, E.M., Cryan, J.F., Dinan, T.G., A distinct profile of tryptophan metabolism along the kynurenine pathway downstream of toll-like receptor activation in irritable bowel syndrome. Frontiers in Pharmacology, 3, 2012, 90.
22. Consortium, H. M. P, Structure, function and diversity of the healthy human microbiome. Nature 486 (2012), 207–214.
23. Crozier, A., Jaganath, I.B., Clifford, M.N., Dietary phenolics: chemistry, bioavailability and effects on health. Natural Product Reports 26 (2009), 1001–1043.
24. Cryan, J.F., Dinan, T.G., Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature Reviews Neuroscience 13 (2012), 701–712.
25. Curran, E.A., Dalman, C., Kearney, P.M., et al. Association between obstetric mode of delivery and autism spectrum disorder: a population-based sibling design study. JAMA Psychiatry, 2015.
26. Curran, E.A., O'Neill, S.M., Cryan, J.F., Kenny, L.C., Dinan, T.G., Khashan, A.S., et al. Research review: birth by caesarean section and development of autism spectrum disorder and attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Journal of Child Psychology and Psychiatry 56 (2015), 500–508.
27. Dantzer, R., Cytokine, sickness behavior, and depression. Immunology and Allergy Clinics of North America 29 (2009), 247–264.
28. Deary, I.J., Corley, J., Gow, A.J., Harris, S.E., Houlihan, L.M., Marioni, R.E., et al. Age-associated cognitive decline. British Medical Bulletin 92 (2009), 135–152.
29. Desbonnet, L., Clarke, G., Shanahan, F., Dinan, T.G., Cryan, J.F., Microbiota is essential for social development in the mouse. Molecular Psychiatry 19 (2014), 146–148.
30. Desbonnet, L., Clarke, G., Traplin, A., O'Sullivan, O., Crispie, F., Moloney, R.D., et al. Gut microbiota depletion from early adolescence in mice: implications for brain and behaviour. Brain, Behavior and Immunity, 2015.
31. Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J., Dinan, T.G., The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. Journal of Psychiatric Research 43 (2008), 164–174.
32. Desideri, G., Kwik-Uribe, C., Grassi, D., Necozione, S., Ghiadoni, L., Mastroiacovo, D., et al. Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment the cocoa, cognition, and aging (CoCoA) study. Hypertension 60 (2012), 794–801.
33. Diaz Heijtz, R., Wang, S., Anuar, F., Qian, Y., Bjorkholm, B., Samuelsson, A., et al. Normal gut microbiota modulates brain development and behavior. Proceedings of the National Academy of Sciences of the United States of America 108 (2011), 3047–3052.
34. Dinan, T.G., Cryan, J.F., Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology. Psychoneuroendocrinology 37 (2012), 1369–1378.
35. Dinan, T.G., Cryan, J.F., Melancholic microbes: a link between gut microbiota and depression?. Neurogastroenterol and Motility 25 (2013), 713–719.
36. Dinan, T.G., Stanton, C., Cryan, J.F., Psychobiotics: a novel class of psychotropic. Biological Psychiatry, 2013.
37. Dinan, T.G., Stilling, R.M., Stanton, C., Cryan, J.F., Collective unconscious: how gut microbes shape human behavior. Journal of Psychiatric Research 63 (2015), 1–9.
38. Duda-Chodak, A., Tarko, T., Satora, P., Sroka, P., Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review. European Journal of Nutrition 54 (2015), 325–341.
39. Dunstan, J.A., Simmer, K., Dixon, G., Prescott, S.L., Cognitive assessment of children at age 2½ years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood - Fetal and Neonatal Edition 93 (2008), F45–F50.
40. Erny, D., Hrabe de Angelis, A.L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nature Neuroscience, 2015 advance online publication.
41. Field, D.T., Williams, C.M., Butler, L.T., Consumption of cocoa flavanols results in an acute improvement in visual and cognitive functions. Physiology & Behavior 103 (2011), 255–260.
42. Flint, H.J., Scott, K.P., Louis, P., Duncan, S.H., The role of the gut microbiota in nutrition and health. Nature Reviews Gastroenterology and Hepatology 9 (2012), 577–589.
43. Foley, K.A., Ossenkopp, K.-P., Kavaliers, M., MacFabe, D.F., Pre- and neonatal exposure to lipopolysaccharide or the enteric metabolite, propionic acid, alters development and behavior in adolescent rats in a sexually dimorphic manner. PLoS One, 9, 2014, e87072.
44. Fontani, G., Corradeschi, F., Felici, A., Alfatti, F., Migliorini, S., Lodi, L., Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects. European Journal of Clinical Investigation 35 (2005), 691–699.
45. Franceschi, C., Bonafe, M., Valensin, S., Olivieri, F., De Luca, M., Ottaviani, E., et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Annals of the New York Academy of Sciences 908 (2000), 244–254.
46. Francis, S., Head, K., Morris, P., Macdonald, I., The effect of flavanol-rich cocoa on the fMRI response to a cognitive task in healthy young people. Journal of Cardiovascular Pharmacology 47 (2006), S215–S220.
47. Freeman, M.P., Hibbeln, J.R., Wisner, K.L., Davis, J.M., Mischoulon, D., Peet, M., et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. Journal of Clinical Psychiatry 67 (2006), 1954–1967.
48. Gomez-Pinilla, F., Tyagi, E., Diet and cognition: interplay between cell metabolism and neuronal plasticity. Current Opinion in Clinical Nutrition and Metabolic Care 16 (2013), 726–733.
49. He, X., Marco, M.L., Slupsky, C.M., Emerging aspects of food and nutrition on gut microbiota. Journal of Agricultural and Food Chemistry 61 (2013), 9559–9574.
50. Hsiao, E.Y., McBride, S.W., Hsien, S., Sharon, G., Hyde, E.R., McCue, T., et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155 (2013), 1451–1463.
51. Huang, T., Zandi, P., Tucker, K., Fitzpatrick, A., Kuller, L., Fried, L., et al. Benefits of fatty fish on dementia risk are stronger for those without APOE ε4. Neurology 65 (2005), 1409–1414.
52. Hyland, N.P., Cryan, J.F., A gut feeling about GABA: focus on GABA(B) receptors. Frontiers in Pharmacology, 1, 2010, 124.
53. Jaremka, L.M., Derry, H.M., Bornstein, R., Prakash, R.S., Peng, J., Belury, M.A., et al. Omega-3 supplementation and loneliness-related memory problems: secondary analyses of a randomized controlled trial. Psychosomatic Medicine 76 (2014), 650–658.
54. Jeffery, I.B., O'Toole, P.W., Ohman, L., Claesson, M.J., Deane, J., Quigley, E.M., et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 61 (2012), 997–1006.
55. Jeffery, I.B., Quigley, E.M., Öhman, L., Simrén, M., O'Toole, P.W., The microbiota link to irritable bowel syndrome: an emerging story. Gut Microbes 3 (2012), 572–576.
56. Jiang, H., Ling, Z., Zhang, Y., Mao, H., Ma, Z., Yin, Y., et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain, Behavior, and Immunity, 2015.
57. Julio-Pieper, M., Bravo, J.A., Aliaga, E., Gotteland, M., Review article: intestinal barrier dysfunction and central nervous system disorders–a controversial association. Alimentary Pharmacology & Therapeutics 40 (2014), 1187–1201.
58. Kankaanpää, P.E., Yang, B., Kallio, H.P., Isolauri, E., Salminen, S.J., Influence of probiotic supplemented infant formula on composition of plasma lipids in atopic infants. The Journal of Nutritional Biochemistry 13 (2002), 364–369.
59. Kennedy, P.J., Cryan, J.F., Dinan, T.G., Clarke, G., Irritable bowel syndrome: a microbiome-gut-brain axis disorder?. World Journal of Gastroenterology: WJG, 20, 2014, 14105.
60. Kessler, R.C., Berglund, P., Demler, O., et al. The epidemiology of major depressive disorder: results from the national comorbidity survey replication (ncs-r). Jama 289 (2003), 3095–3105.
61. Kessler, R.C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K.R., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). Jama 289 (2003), 3095–3105.
62. Knights, D., Ward, T.L., McKinlay, C.E., Miller, H., Gonzalez, A., McDonald, D., et al. Rethinking “enterotypes”. Cell Host & Microbe 16 (2014), 433–437.
63. Krikorian, R., Nash, T.A., Shidler, M.D., Shukitt-Hale, B., Joseph, J.A., Concord grape juice supplementation improves memory function in older adults with mild cognitive impairment. British Journal of Nutrition 103 (2010), 730–734.
64. Krikorian, R., Shidler, M.D., Nash, T.A., Kalt, W., Vinqvist-Tymchuk, M.R., Shukitt-Hale, B., et al. Blueberry supplementation improves memory in older adults†. Journal of Agricultural and Food Chemistry 58 (2010), 3996–4000.
65. Laparra, J.M., Sanz, Y., Interactions of gut microbiota with functional food components and nutraceuticals. Pharmacological Research 61 (2010), 219–225.
66. Letenneur, L., Proust-Lima, C., Le Gouge, A., Dartigues, J.F., Barberger-Gateau, P., Flavonoid intake and cognitive decline over a 10-year period. American Journal of Epidemiology 165 (2007), 1364–1371.
67. Lyte, M., Probiotics function mechanistically as delivery vehicles for neuroactive compounds: microbial endocrinology in the design and use of probiotics. Bioessays 33 (2011), 574–581.
68. MacFabe, D.F., Cain, N.E., Boon, F., Ossenkopp, K.P., Cain, D.P., Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: relevance to autism spectrum disorder. Behavioural Brain Research 217 (2011), 47–54.
69. Macfarlane, S., Macfarlane, G.T., Regulation of short-chain fatty acid production. Proceedings of the Nutrition Society 62 (2003), 67–72.
70. Malkova, N.V., Yu, C.Z., Hsiao, E.Y., Moore, M.J., Patterson, P.H., Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain, Behavior, and Immunity 26 (2012), 607–616.
71. Mayer, E., Knight, R., Mazmanian, S.K., Cryan, J.F., Tillisch, K., Gut microbes and the brain: paradigm shift in neuroscience. The Journal of Neuroscience 34 (2014), 15490–15496.
72. McKernan, D., Fitzgerald, P., Dinan, T., Cryan, J., The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat. Neurogastroenterology & Motility 22 (2010), 1029–e1268.
73. Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. British Journal of Nutrition 105 (2011), 755–764.
74. Naseribafrouei, A., Hestad, K., Avershina, E., Sekelja, M., Linløkken, A., Wilson, R., et al. Correlation between the human fecal microbiota and depression. Neurogastroenterology & Motility 26 (2014), 1155–1162.
75. Neufeld, K.M., Kang, N., Bienenstock, J., Foster, J.A., Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 23 (2011), 255–264 e119.
76. O'Brien, S.M., Scott, L.V., Dinan, T.G., Cytokines: abnormalities in major depression and implications for pharmacological treatment. Human Psychopharmacology: Clinical and Experimental 19 (2004), 397–403.
77. O'Mahony, S.M., Felice, V.D., Nally, K., Savignac, H.M., Claesson, M.J., Scully, P., et al. Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats. Neuroscience 277 (2014), 885–901.
78. Ogbonnaya, E.S., Clarke, G., Shanahan, F., Dinan, T.G., Cryan, J.F., O'Leary, O.F., Adult hippocampal neurogenesis is regulated by the microbiome. Biological Psychiatry, 2015.
79. O'Mahony, S.M., Clarke, G., Borre, Y.E., Dinan, T.G., Cryan, J.F., Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behavioural Brain Research 277 (2015), 32–48.
80. Palmer, C., Bik, E.M., DiGiulio, D.B., Relman, D.A., Brown, P.O., Development of the human infant intestinal microbiota. PLoS Biology, 5, 2007, e177.
81. Pan, H., Feng, J., He, G.X., Cerniglia, C.E., Chen, H., Evaluation of impact of exposure of Sudan azo dyes and their metabolites on human intestinal bacteria. Anaerobe 18 (2012), 445–453.
82. Pase, M.P., Scholey, A.B., Pipingas, A., Kras, M., Nolidin, K., Gibbs, A., et al. Cocoa polyphenols enhance positive mood states but not cognitive performance: a randomized, placebo-controlled trial. Journal of Psychopharmacology 27 (2013), 451–458.
83. Peet, M., Brind, J., Ramchand, C., Shah, S., Vankar, G., Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia. Schizophrenia Research 49 (2001), 243–251.
84. Power, S.E., O'Toole, P.W., Stanton, C., Ross, R.P., Fitzgerald, G.F., Intestinal microbiota, diet and health. British Journal of Nutrition 111 (2014), 387–402.
85. Prenderville, J.A., Kennedy, P.J., Dinan, T.G., Cryan, J.F., Adding fuel to the fire: the impact of stress on the ageing brain. Trends Neuroscience 38 (2015), 13–25.
86. Pusceddu, M.M., Kelly, P., Ariffin, N., Cryan, J.F., Clarke, G., Dinan, T.G., n-3 PUFAs have beneficial effects on anxiety and cognition in female rats: effects of early life stress. Psychoneuroendocrinology 58 (2015), 79–90.
87. Rao, A.V., Bested, A.C., Beaulne, T.M., Katzman, M.A., Iorio, C., Berardi, J.M., et al. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathogens 1 (2009), 1–6.
88. Rechel, B., Grundy, E., Robine, J.M., Cylus, J., Mackenbach, J.P., Knai, C., et al. Ageing in the european union. Lancet 381 (2013), 1312–1322.
89. Rodríguez, J.M., Murphy, K., Stanton, C., Ross, R.P., Kober, O.I., Juge, N., et al. The composition of the gut microbiota throughout life, with an emphasis on early life. Microbial Ecology in Health and Disease, 26, 2015.
90. Sampson, T.R., Mazmanian, S.K., Control of brain development, function, and behavior by the microbiome. Cell Host & Microbe 17 (2015), 565–576.
91. Sandler, R.H., Finegold, S.M., Bolte, E.R., Buchanan, C.P., Maxwell, A.P., Vaisanen, M.L., et al. Short-term benefit from oral vancomycin treatment of regressive-onset autism. Journal of Child Neurology 15 (2000), 429–435.
92. Savignac, H.M., Kiely, B., Dinan, T.G., Cryan, J.F., Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice. Neurogastroenterology & Motility, 2014 n/a-n/a.
93. Schaffer, S., Halliwell, B., Do polyphenols enter the brain and does it matter? Some theoretical and practical considerations. Genes Nutrition 7 (2012), 99–109.
94. Schmidt, K., Cowen, P.J., Harmer, C.J., Tzortzis, G., Errington, S., Burnet, P.W., Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology (Berl) 232 (2015), 1793–1801.
95. Selma, M.V., Espin, J.C., Tomas-Barberan, F.A., Interaction between phenolics and gut microbiota: role in human health. Journal of Agricultural and Food Chemistry 57 (2009), 6485–6501.
96. Shanahan, F., Quigley, E.M., Manipulation of the microbiota for treatment of IBS and IBD—Challenges and controversies. Gastroenterology, 2014.
97. Simopoulos, A.P., The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedicine & Pharmacotherapy 56 (2002), 365–379.
98. Slavin, J., Fiber and prebiotics: mechanisms and health benefits. Nutrients 5 (2013), 1417–1435.
99. Smith, A.P., Sutherland, D., Hewlett, P., An investigation of the acute effects of oligofructose-enriched inulin on subjective wellbeing, mood and cognitive performance. Nutrients 7 (2015), 8887–8896.
100. Sonuga-Barke, E.J., Brandeis, D., Cortese, S., Daley, D., Ferrin, M., Holtmann, M., et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. American Journal of Psychiatry 170 (2013), 275–289.
101. Steenbergen, L., Sellaro, R., van Hemert, S., Bosch, J.A., Colzato, L.S., A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain, Behavior, and Immunity, 2015.
102. Stilling, R.M., Dinan, T.G., Cryan, J.F., Microbial genes, brain & behaviour - epigenetic regulation of the gut-brain axis. Genes Brain and Behavior 13 (2014), 69–86.
103. Stilling, R.M., Ryan, F.J., Hoban, A.E., Shanahan, F., Clarke, G., Claesson, M.J., et al. Microbes & neurodevelopment-absence of microbiota during early life increases activity-related transcriptional pathways in the amygdala. Brain, Behavior, and Immunity, 2015.
104. Strauss, E., da Costa, M.F., The importance of bacterial infections as precipating factors of chronic hepatic encephalopathy in cirrhosis. Hepatogastroenterology 45 (1998), 900–904.
105. Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X.N., et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. The Journal of Physiology 558 (2004), 263–275.
106. Tillisch, K., Labus, J.S., Advances in imaging the brain-gut axis: functional gastrointestinal disorders. Gastroenterology 140 (2011), 407–411 e401.
107. Tillisch, K., Labus, J., Kilpatrick, L., Jiang, Z., Stains, J., Ebrat, B., et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 144:1394–1401 (2013), e1391–1394.
108. Valdes, L., Cuervo, A., Salazar, N., Ruas-Madiedo, P., Gueimonde, M., González, S., Relationship between phenolic compounds from diet and microbiota: impact on human health. Food & Function, 2015.
109. Wall, R., Marques, T.M., O'Sullivan, O., Ross, R.P., Shanahan, F., Quigley, E.M., et al. Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota. The American Journal of Clinical Nutrition 95 (2012), 1278–1287.
110. Wightman, E.L., Reay, J.L., Haskell, C.F., Williamson, G., Dew, T.P., Kennedy, D.O., Effects of resveratrol alone or in combination with piperine on cerebral blood flow parameters and cognitive performance in human subjects: a randomised, double-blind, placebo-controlled, cross-over investigation. British Journal of Nutrition 112 (2014), 203–213.
111. Zhang, X.-W., Hou, W.-S., Li, M., Tang, Z.-Y., Omega-3 fatty acids and risk of cognitive decline in the elderly: a meta-analysis of randomized controlled trials. Aging Clinical and Experimental Research, 2015, 1–2.